全球心脏影像学在心脏结节病中的应用实践:国际专家调查与德尔菲共识研究
该国际多学科德尔菲研究纳入89名心脏结节病专家(代表13个国家61个中心),评估心脏影像在疑似或确诊心脏结节病中的适应证阈值、判读与随访间隔。第一轮46项中22项(48%)达成共识,第二轮29项中21项(72%)达成共识;FDG-PET与CMR并列为初始诊断的重要共同主要模态,但LGE和FDG摄取的量化阈值未达成共识。
要点
- 确诊心外结节病患者出现新发心律异常或超声心动图提示心室功能障碍时,专家对启用先进心脏影像的阈值较低。
- FDG-PET与心脏磁共振并列为心脏结节病初始诊断的重要共同主要模态。
- 若CMR为首选检查,无论结果异常还是正常(中高验前概率时),专家共识均支持后续行FDG-PET。
核心结论
- 研究在疑似和确诊心脏结节病的心脏影像应用方面确定了若干共识领域,并识别出未来前瞻性、对照、多中心研究的优先方向。
研究设计与样本
- 国际多学科专家小组完成的改良两轮德尔菲研究,第一轮89名、第二轮75名专家参与,代表13个国家61个中心,共识预先定义为≥70%同意或不同意。
诊断标准与关键数值
- 共识阈值预先定义为≥70%的同意或不同意。
- 第一轮46项中22项(48%)达成共识,第二轮29项中21项(72%)达成共识。
- 确诊心外结节病患者出现新发心律异常或超声心动图发现心室功能障碍时,启用先进心脏影像的阈值较低。
- FDG-PET与CMR并列为初始诊断的重要共同主要模态。
- 若CMR为首选检查,任何异常CMR结果后均共识支持行FDG-PET;心脏结节病验前概率中或高时,即使CMR正常也共识支持行FDG-PET。
临床应用与阅片要点
- 确诊心外结节病患者出现新发心律异常或超声心动图提示心室功能障碍时,专家对启用先进心脏影像的阈值较低。
- FDG-PET与CMR并列为初始诊断的重要共同主要模态。
- CMR为首选检查时,异常结果后共识支持行FDG-PET;验前概率中或高时即使CMR正常也共识支持行FDG-PET。
- 晚期钆增强量化被认为重要,但风险阈值及最佳量化方法未达成共识。
- FDG摄取降低是指导治疗反应的重要因素,但最佳量化方法及充分影像学反应的定义未达成共识。
局限性
- 研究指出在晚期钆增强的风险阈值及最佳量化方法上未达成共识。
- 研究指出在FDG摄取的最佳量化方法及充分影像学反应的定义上未达成共识。
- 研究结论提出需未来前瞻性、对照、多中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Cardiac imaging is a cornerstone in the initial diagnosis, management, and follow-up of cardiac sarcoidosis. However, ordering thresholds, access, and follow-up imaging vary across the globe.
OBJECTIVES: A Delphi study was conducted to define areas of consensus and areas requiring further study in the use of cardiac imaging in suspected or established cardiac sarcoidosis.
METHODS: An international, multidisciplinary panel of experts in cardiac sarcoidosis completed a modified 2-round Delphi study. The study evaluated clinical decision making regarding the use of cardiac imaging, including indication thresholds, interpretation, and interval follow-up imaging. Consensus was defined a priori as ≥70% agreement or disagreement.
RESULTS: A total of 89 experts in cardiac sarcoidosis (89 in round 1 and 75 in round 2) participated, representing 61 centers in 13 countries. Consensus was reached on 22 of 46 items (48%) in round 1 and 21 of 29 items (72%) in round 2. There was a low threshold to order advanced cardiac imaging for new rhythm abnormalities or ventricular dysfunction detected on echocardiography in patients with established extracardiac sarcoidosis. 18F-fluorodeoxyglucose (FDG) positron emission tomography was an important co-primary modality with cardiac magnetic resonance (CMR) for initial diagnosis. If CMR was the first test, there was consensus to proceed to FDG-positron emission tomography after any abnormal CMR result or even after normal CMR result in the setting of moderate or high pretest probability for cardiac sarcoidosis. There was consensus that late gadolinium enhancement quantification was important, but there was no consensus on the threshold of risk or on how best to quantify late gadolinium enhancement. Similarly, reduction in FDG uptake was an important factor in guiding treatment response, but there was no consensus on how to best quantify FDG uptake or what constituted an adequate radiographic response.
CONCLUSIONS: Several consensus areas for cardiac imaging in suspected and established cardiac sarcoidosis were identified. This consensus study identified areas of priority for future prospective, controlled, multicenter research studies.
引用
- Kafil TS, Ribeiro Neto ML, Judson MA, et al. Global Practices in Cardiac Imaging for Cardiac Sarcoidosis: A Survey Study of International Experts With Delphi Consensus. JACC Cardiovasc Imaging. 2025. PMID: 40467149. doi:10.1016/j.jcmg.2025.02.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。